CWM
FULC icon

CIBC World Markets’s Fulcrum Therapeutics FULC Stock Holding History

CIBC World Markets’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,949
Closed -$34.4K – 1697
2025
Q1 		$34.4K Buy
+11,949
New +$43.9K ﹤0.01% 1759
2024
Q2 		– Sell
-150,000
Closed -$1.42M – 737
2024
Q1 		$1.42M Buy
+150,000
New +$1.34M 0.01% 587

Other funds holding FULC

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIBC World Markets's FULC Position: Q2 2025 in Review

CIBC World Markets sold out of Fulcrum Therapeutics (FULC) in Q2 2025, closing a stake of 11,949 shares — an estimated $34.4K sold.

CIBC World Markets first reported a position in FULC in Q1 2024 and held it in 2 quarters. The position peaked at $1.42M in Q1 2024. 122 funds tracked by Wall St. Rank hold FULC as of Q2 2025.

  • CIBC World Markets reported no remaining Fulcrum Therapeutics position as of Q2 2025 after selling out during the quarter.
  • CIBC World Markets sold 11,949 Fulcrum Therapeutics shares in Q2 2025, an estimated $34.4K.
  • CIBC World Markets first reported a position in Fulcrum Therapeutics in Q1 2024 and held it in 2 quarters.
  • CIBC World Markets's Fulcrum Therapeutics position peaked at $1.42M in Q1 2024.
  • 122 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q2 2025.

Based on CIBC World Markets's 13F filing for Q2 2025, filed 14 Aug 2025.